Videos

HER2-positive Breast Cancer: Pre-operative Therapies

October 29th 2021

Dr. Julie Fisher, an expert oncologist, describes the range of treatment options for HER2-positive breast cancer in the pre-operative setting.

Educated Patient® Webinar: Understanding Myeloproliferative Neoplasms (MPNs) and Treatment Options

October 28th 2021

View the full CURE® Educated Patient® Webinar: Understanding Myeloproliferative Neoplasms (MPNs) and Treatment Options on demand.

Lung Cancer Heroes Awards 2021

October 28th 2021

Watch the entire Lung Cancer Heroes® presentation here!

The Importance of Shared Decision-Making in Receiving Molecular Testing for NSCLC

October 28th 2021

Stephen Liu, MD, and Danielle Hicks clarify the importance of involving patients and caregivers in discussions about non-small cell lung cancer molecular testing.

Targeted Therapies in Non-Small Cell Lung Cancer

October 28th 2021

Thought leaders give an overview on KRAS-mutated non-small cell lung cancer and the treatment options available.

Importance of Support Groups in Metastatic Breast Cancer

October 27th 2021

Lisa Laudico provides insight into the value of support groups in metastatic breast cancer.

Self-Inventory for Metastatic Breast Cancer

October 27th 2021

Julie Larson, LCSW, discusses the concept of self-inventory and questions patients may ask themselves to evaluate their health.

Curing Stomach Cancer Month

October 25th 2021

Debbie's Dream Foundation wants every state to recognize November as Curing Stomach Cancer Month, so we've made it easy for you to help make this happen.

Educated Patient® Kidney Cancer Summit: October 24, 2021

October 24th 2021

View the full CURE Educated Patient Kidney Cancer Summit on demand.

Repeat Biopsies as NSCLC Progresses

October 22nd 2021

Preferences for repeat biopsies upon progression in non-small cell lung cancer following frontline therapy with a targeted treatment approach.

Being Diagnosed With HER2-positive Breast Cancer

October 22nd 2021

Jocelyn Mueller, a patient with HER2-positive breast cancer, explains how she received her diagnosis.

PD-L1 Testing in NSCLC

October 22nd 2021

The pros and cons of conducting PD-L1 testing in patients with non-small cell lung cancer.

An Overview of HER2-positive Breast Cancer

October 22nd 2021

Julie Fisher, MD, gives a brief overview of HER2-positive breast cancer and the tests available for diagnosis.

Biomarker Testing and the Impact on Treatment Selection for NSCLC

October 21st 2021

Stephen Liu, MD, and Danielle Hicks illustrate how molecular testing impacts targeted therapy selection in non-small cell lung cancer.

Discussing Biomarker Testing in NSCLC With Patients

October 21st 2021

Key opinion leaders explain how to discuss biomarker testing with non-small cell lung cancer patients, as well as the common questions they field.

Self-Care in Metastatic Breast Cancer

October 21st 2021

People living with metastatic breast cancer share highlights of their personal self-care strategies.

Coping with a Metastatic Breast Cancer Diagnosis

October 21st 2021

Julie Larson, LCSW, and a panel of women living with metastatic breast discuss the impact of the disease on mental health and resources to consider as a patient.

3 Things to Look for When Reading Cancer Research

October 18th 2021

Knowing the type, phase and eligibility criteria is key in reading cancer research.

Individualized Treatment Decisions for Patients With NSCLC

October 15th 2021

The rationale for waiting on results of molecular testing prior to initiating treatment for patients with non-small cell lung cancer.

Tissue and Liquid Biopsies in NSCLC

October 15th 2021

The difference between tissue and liquid biopsies used in non-small cell lung cancer, and what patients should know about their results and treatment decision-making.

Biomarker Testing in Non-Small Cell Lung Cancer

October 14th 2021

Stephen Liu, MD, and Danielle Hicks describe the purpose and the importance of biomarker testing in non-small cell lung cancer.

NSCLC: Future Directions in Care and Take-Home Messages

October 14th 2021

Shared insight on novel treatments for non-small cell lung cancer and how patients should advocate for themselves and seek best available care.

Non-Small Cell Lung Cancer: Taking a Break From Treatment

October 14th 2021

Allison Collins shares her experience undergoing a break from therapy after she responded well to treatment for non-small cell lung cancer.

Social Impact of Metastatic Breast Cancer Diagnosis

October 13th 2021

The panel discusses the social impact of metastatic breast cancer diagnosis on the relationships in their lives.

Stories of Metastatic Breast Cancer Diagnosis

October 13th 2021

Shirley Mertz, MA, JD, Lisa Laudico, and Sheila McGlown share their stories of being diagnosed with metastatic breast cancer.

How Surviving Cancer Made One Oncologist More Empathetic to His Patients

October 8th 2021

After undergoing treatment for leukemia in the middle of his career as a radiation oncologist, Dr. Curtis Mack noticed that he became a more empathetic and patient doctor.

Counseling Patients With NSCLC About Molecular Testing

October 8th 2021

What patients need to know about molecular testing and treatment decisions in non-small cell lung cancer.

Addressing Barriers to Molecular Testing in NSCLC

October 8th 2021

Reactions to low rates of molecular testing for patients with non-small cell lung cancer in community settings.

The Importance of Clinical Trials in Non-Small Cell Lung Cancer

October 7th 2021

A brief discussion on the importance of enrolling in clinical trials and when that may be an option in non-small cell lung cancer.

NSCLC: What Are Biomarkers and How Do They Affect Treatment?

October 7th 2021

An in-depth explanation of biomarkers in non-small cell lung cancer, particularly how they can affect the disease and treatment options.